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This dissertation aims to shed light on translational aspects to move from genetic 
reductionism toward holistic systems thinking in personalized medicine (PM). 
Summarized the approach will shed light on (1) the development of societal 
awareness and ethical argumentations to inform political decision making, (2) the 
integration of Big Data and ICT in the development of PM, (3) practical applica-
tions investigated in the context of chronic complex disease, (4) the inclusion of 
lifestyle and its preventive potential when applied in a personalized manner and 
(5) the overall challenges on the path towards a sustainable health care system. 
According to the definition of the European Commission Horizon 2020 Advi-
sory Group for Societal Challenge, “Health, Demographic Change and Wellbeing” 
PM refers to “a medical model using characterization of individuals’ phenotypes 
and genotypes (e.g. molecular profiling, medical imaging, lifestyle data) for tailor-
ing the right therapeutic strategy for the right person at the right time, and to de-
termine the predisposition to disease and deliver timely and targeted prevention.”  
Current first success stories are mainly reported in the field of oncology. Tar-
geted testing for specific genetic abnormalities has been transforming the classi-
fication and treatment. However, development and implementation of PM ap-
proaches for other diseases and many aspects of health care delivery are still far 
from being reality. Genetics are just one of a suite of personalized tools to achieve 
healthier living, rather than an almighty method to reliable predicts future disease. 
Despite various calls for a more holistic view of PM, this term or alternatively 
system medicine remain proxies for the application of genetics to individualized 
therapies. In the present dissertation, the five SRIA of challenges have been cho-
sen as a frame of orientation and horizontal guideline. The aim is to fill the chal-
lenges with scientific investigations, original data and specific examples, to shed 
light on translations aspects in order to move from a genetic focus towards more 
holistic systems thinking in PM. 
Developing Awareness and Empowerment: Case of Personal 
Genomics 
Given the overall need for genomic data to receive further insights into the com-
plex system of health and disease, the first objective was to investigate the soci-
etal perception of research participation, the value people attribute to genetic re-
search and the types of trade-offs between privacy and utility that people are 
willing to accept. 
In Part 1, attitudes of Swiss older adults towards personal genomics and peo-
ples’ willingness to engage and share their genetic data for research have been 
explored. The study indicated a positive overall attitude towards personal ge-
nomic testing among older Swiss adults, a group not typically represented in 
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studies about personal genomics. Main drivers were the possibility to access their 
personal disease risk and the opportunity to contribute to scientific research. 
Based on Part 1 we can conclude, that an increased focus on general public 
engagement, especially of older adults, in scientific research activities known as 
“citizen science” initiated by public research institutions may further strengthen 
the uptake of PM.  
Big Data 
Part 2 illustrates how to integrate the infinite amount of emerging data, known as 
Big Data to support the development the specific cases of policy making. For 
effective, high quality policy making in the context of public health we need to 
reshape the process of policy making using continuous, real time data inflow. In 
detail, the objective of Part 2 was to investigate the potential of Big Data as a 
support tool for making innovative decisions in public health policy making. Based 
on the findings, it has been concluded that the value and necessity of a pan-
European data sharing platform or (Health) Data Cooperatives is its function as 
a tool to tap into the potential of all existing and rapidly emerging data sources. 
Such a Data Common would enable to leverage all the data required to overcome 
computational, algorithmic and technological challenges that characterize today’s 
highly heterogeneous data landscape, as well a host of diverse regulatory, nor-
mative, governance and policy constraints.  
Translating Basic to Clinical Research and Beyond: Chronic 
Complex Disease  
A majority diseases is caused by lifestyle issues: Nutrition, exercise and environ-
ment. However, medicine has not yet tapped into this potential. The need for PM 
derives from the realization that today’s most challenging medical conditions are 
chronic complex diseases with multiple pathogenic components that interact with 
each other. Currently, complex diseases cannot properly be controlled and much 
less cured by modulating single components at sporadic time points in the course 
of the disease or administering the same treatment to all patients. Lifestyle inter-
ventions namely physical activity have been tested as a promising intervention in 
a large variety of chronic inflammatory diseases to improve inflammation along 
with sleep quality, mental well-being, fitness and daily physical activity. Therefore, 
objective 3 was to explore the influence of a lifestyle intervention including regular 
physical activity on inflammation, fitness, depression and sleep among pediatric 
patients with IBD. In summary, the four articles showed that participants with IBD 
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in an active state of the disease (IBD-AD) showed higher markers of inflamma-
tion, had lower psychological functioning, impaired objective sleep and lower PA 
(average steps per day) compared to participants with IBD in remission (IBD-RE) 
and healthy controls (HC). After an 8-week physical activity intervention exercise 
capacity improved in all participants, self-reported fitness and daily physical ac-
tivity increased in IBD-AD, but not in IBD-RE and HC. No improvements were 
observed for psychological functioning, depressive symptoms or subjective 
sleep. Objective sleep improved, deep sleep increased, light sleep decreased, 
and in the IBD-AD group the number of arousals after sleep onset also de-
creased. Finally, after a single bout of exercise inflammation markers strongly 
increased in all three groups, while after a long-term AET intervention, inflamma-
tion significantly decreased. 
In conclusion, the integration of lifestyle into medical practice is one step to 
add and provide additional treatment options and recognize the importance of 
lifestyle and behavior change as an integral part and opportunity to increase treat-
ment effectiveness and reduce costs. The increased efficacy through personali-
zation will lead to empowerment, feeling of self-efficacy and regaining of control 
for chronically ill patients to improve health outcomes based on individual health 
metrics and personal preferences. 
Bridging Innovation to the Market: mHelath and Business 
opportunities 
A crucial tool in terms of innovation and development towards the notion of PM 
is mobile health (mhealth). The convergence of wearable electronics, miniatur-
ized sensor technologies, and mobile phone penetration provides novel opportu-
nities for personalized lifestyle interventions and support of health care practice. 
For example, the positive effects of regular physical activity are well known, yet 
many people do not comply with physical activity guidelines. General practition-
ers and other medical professionals often don’t have time to encourage inactive 
patients or personalize their lifestyle advice to the patient’s needs. As soon as 
people start moving, it is important to maintain this behavior, a second barrier 
many people fail. Physical Activity Behavior is highly dynamic, momentary and 
embedded in context. With a business plan, Part 4 will propose a tool to translate 
scientific evidence on behavior change into a personalized program to support 
GPs and empower patients to start a physically active life. Aiming towards holistic 
PM, MoVit is a concrete example on how to empower patients and health care 
professionals to integrate evidence based lifestyle advices into clinical practice. 
MHealth again, produces data that might improve patient self-efficacy, health lit-
eracy and may contribute towards decision making in the health care context. 
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Shaping Sustainable Healthcare: Discussion and Future 
scenarios 
With the promise of PM to improve outcomes by providing treatment to the right 
patient, at the right dosage, at the right time and avoiding the trial and error based 
traditional “one-size fits all” approach, new opportunities emerged to reach the 
health care systems goals. Understandably, this development is expected to re-
duce the economic burden health care systems are facing due to adverse treat-
ment effects, incomplete benefits or misdiagnosis. At the same time, the chang-
ing medical model will create new demands on the health care system. Objective 
5 was to investigate the role of health care systems and policy making, when 
shifting focus from traditional disease categorization towards unique disease pro-
files.  
In conclusion for Part 5, as well as overall, the implementation of PM will need 
a paradigm shift from multiple stakeholders and the health care system towards 
holistic systems thinking to realize truly PM. Technology will be the main driver in 
the fast development. However, patient-centeredness should be the ultimate goal 
of personalization. Therefore, the paradigm of PM should remain flexible and dy-
namic to integrate exponentially growing technology, incorporate lifestyle and en-
vironmental medicine and place the patient at center: Lean Personalized Medi-
cine.  
